Cellectar Biosciences (CLRB): A Highly Undervalued Play

[tdc_zone][vc_row][vc_column][td_block_text_with_title f_post_font_weight=”200″ f_post_font_style=”italic”]

[/td_block_text_with_title][tdm_block_image_info_box box_style=”style-2″ box_overlay=”eyJ0eXBlIjoiZ3JhZGllbnQiLCJjb2xvcjEiOiIjOGRiMjhkIiwiY29sb3IyIjoicmdiYSgwLDE5LDM4LDAuOCkiLCJtaXhlZENvbG9ycyI6W10sImRlZ3JlZSI6IjMwIiwiY3NzIjoiYmFja2dyb3VuZDogLXdlYmtpdC1saW5lYXItZ3JhZGllbnQoMzBkZWcscmdiYSgwLDE5LDM4LDAuOCksIzhkYjI4ZCk7YmFja2dyb3VuZDogbGluZWFyLWdyYWRpZW50KDMwZGVnLHJnYmEoMCwxOSwzOCwwLjgpLCM4ZGIyOGQpOyIsImNzc1BhcmFtcyI6IjMwZGVnLHJnYmEoMCwxOSwzOCwwLjgpLCM4ZGIyOGQifQ==” tds_button=”tds_button3″ button_size=”tdm-btn-md” button_icon_size=”18″ button_tdicon=”tdc-font-fa tdc-font-fa-graduation-cap” box_title=”STOCK PICK: Cellectar Biosciences, Inc. (NASDAQ: CLRB)” box_description=”TXVsdGlwbGUlMjBuZWFyLXRlcm0lMjBjYXRhbHlzdHMlMjBhaGVhZC4lMjA=” media_size_image_height=”733″ media_size_image_width=”1000″ box_image=”2077″ f_descr_font_weight=”800″][/vc_column][/vc_row][vc_row][vc_column width=”2/3″][vc_single_image media_size_image_height=”754″ media_size_image_width=”1000″ image=”2061″][/vc_column][vc_column width=”1/3″][tdm_block_column_content title_text=”QWJvdXQlMjBDTFJC” title_tag=”h3″ title_size=”tdm-title-md” url=”https://research.tdameritrade.com/grid/public/research/stocks/summary?symbol=CLRB” open_in_new_window=”yes” description=”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” button_text=”Buy CLRB Shares At TD Ameritrade” content_align_horizontal=”content-horiz-center” button_url=”https://research.tdameritrade.com/grid/public/research/stocks/summary?symbol=CLRB” tds_title1-title_color=”#30b22e” tds_button1-background_color=”#30b22e”][/vc_column][/vc_row][vc_row][vc_column][tdm_block_testimonial description=”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” content_align_horizontal=”content-horiz-center” media_size_image_height=”249″ media_size_image_width=”249″ tds_testimonial=”tds_testimonial3″ tds_testimonial3-name_color=”#30b22e”][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][tdm_block_column_content title_text=”MyUyME9uZ29pbmclMjBDbGluaWNhbCUyMFRyaWFscw==” title_tag=”h3″ title_size=”tdm-title-md” image2=”//alphastocknews.com/wp-content/plugins/td-composer/assets/images/placeholders/thumb_02.jpg” description=”Q2VsbGVjdGFyJTIwQmlvc2NpZW5jZXMnJTIwbGVhZCUyMFBEQyUyMHJhZGlvdGhlcmFwZXV0aWMlMkMlMjBrbm93biUyMGFzJTIwQ0xSJTIwMTMxJTIwaXMlMjB0aGUlMjBzdWJqZWN0JTIwb2YlMjAzJTIwb25nb2luZyUyMGNsaW5pY2FsJTIwdHJpYWxzLiUyMEluJTIwdGhlc2UlMjB0cmlhbHMlMkMlMjBDTFJCJTIwaXMlMjB0YXJnZXRpbmclMjByZWxhcHNlZCUyMG9yJTIwcmVmcmFjdG9yeSUyMGhlbWF0b2xvZ2ljJTIwbWFsaWduYW5jaWVzJTIwaW5jbHVkaW5nJTIwbXVsdGlwbGUlMjBteWVsb21hJTJDJTIwYW5kJTIwcGVkaWF0cmljJTIwbWFsaWduYW5jaWVzLiUyMA==” media_size_image_height=”1810″ media_size_image_width=”2560″ tds_title1-title_color=”#30b22e” image1=”2062″][/vc_column][vc_column width=”1/3″][tdm_block_column_content title_tag=”h3″ title_size=”tdm-title-md” image2=”//alphastocknews.com/wp-content/plugins/td-composer/assets/images/placeholders/thumb_02.jpg” description=”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” media_size_image_height=”1706″ media_size_image_width=”2560″ tds_title1-title_color=”#30b22e” title_text=”S2V5JTIwUmVjZW50JTIwQWNoaWV2ZW1lbnRz” image1=”2063″][/vc_column][vc_column width=”1/3″][tdm_block_column_content title_text=”TXVsdGlwbGUlMjBDYXRhbHlzdHMlMjBBaGVhZA==” title_tag=”h3″ title_size=”tdm-title-md” image2=”//alphastocknews.com/wp-content/plugins/td-composer/assets/images/placeholders/thumb_02.jpg” media_size_image_height=”750″ media_size_image_width=”1000″ description=”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” tds_title1-title_color=”#30b22e” image1=”2064″][/vc_column][/vc_row][vc_row][vc_column][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][td_block_text_with_title custom_title=”Radiotherapeutic Market Opportunity” header_color=”#30b22e”]

It is estimated by Research & Markets that the radiotherapeutic market will generate $9.3 billion in 2020 as the market continues to grow with a CAGR of 10.2% through 2025.

Recently, we’ve seen acquisitions in the radiotherapeutics market, with Novartis buying Advanced Accelerator Applications for $3.9 billion and Endocyte for $2.1 billion!

[/td_block_text_with_title][tdm_block_button button_text=”Buy CLRB Shares At TD Ameritrade” button_size=”tdm-btn-md” button_display=”tdm-block-button-full” tdc_css=”eyJhbGwiOnsiZGlzcGxheSI6IiJ9fQ==” tds_button1-background_color=”#30b22e” button_url=”https://research.tdameritrade.com/grid/public/research/stocks/summary?symbol=CLRB”][/vc_column][/vc_row][vc_row][vc_column][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/2″][tdm_block_column_content title_tag=”h3″ title_size=”tdm-title-md” image2=”//alphastocknews.com/wp-content/plugins/td-composer/assets/images/placeholders/thumb_02.jpg” description=”TGVhcm4lMjBtb3JlJTIwYWJvdXQlMjB0aGlzJTIwY29tcGVsbGluZyUyMG9wcG9ydHVuaXR5JTIwYnklMjBkaXZpbmclMjBpbnRvJTIwdGhlJTIwQ2VsbGVjdGFyJTIwQmlvc2NpZW5jZXMlMjBGYWN0JTIwU2hlZXQuJTIw” title_text=”RGl2ZSUyMEludG8lMjBUaGUlMjBEZXRhaWxz” media_size_image_height=”1696″ media_size_image_width=”2560″ button_text=”Access the Fact Sheet Here” button_url=”https://alphastocknews.com/wp-content/uploads/2019/12/CLRB-Factsheet-Q32019.pdf” content_align_horizontal=”content-horiz-center” tdc_css=”eyJhbGwiOnsiYm9yZGVyLWNvbG9yIjoiIzJlYjIyYyIsImRpc3BsYXkiOiIifX0=” tds_button1-background_color=”#2eb22c” tds_title1-title_color=”#2eb22c” image1=”2065″][/vc_column][vc_column width=”1/2″][tdm_block_column_content title_tag=”h3″ title_size=”tdm-title-md” image2=”//alphastocknews.com/wp-content/plugins/td-composer/assets/images/placeholders/thumb_02.jpg” description=”TGVhcm4lMjBtb3JlJTIwYWJvdXQlMjBQREMlMjBjb21wb3VuZHMlMkMlMjBzdHJpZGVzJTIwdGhhdCUyMENMUkIlMjBpcyUyMG1ha2luZyUyQyUyMGFuZCUyMG1vcmUlMjB3aXRoJTIwdGhlJTIwaW52ZXN0b3IlMjBkZWNrJTIwYmVsb3ch” button_url=”https://alphastocknews.com/wp-content/uploads/2019/12/CLRB-Corp.-Presentation-12-3-19.pdf” button_text=”Access The CLRB Investor Deck” tds_button1-background_color=”#2eb22c” tds_title1-title_color=”#2eb22c” media_size_image_height=”1707″ media_size_image_width=”2560″ content_align_horizontal=”content-horiz-center” title_text=”Q2hlY2slMjBPdXQlMjBUaGUlMjBJbnZlc3RvciUyMFByZXNlbnRhdGlvbg==” image1=”2066″][/vc_column][/vc_row][vc_row full_width=”stretch_row_1200 td-stretch-content”][vc_column][tdm_block_call_to_action title_text=”UmVhZCUyMENMUkIncyUyMFNFQyUyMEZpbGluZ3M=” title_size=”tdm-title-md” description=”Q2xpY2slMjB0aGUlMjBidXR0b24lMjB0byUyMHRoZSUyMHJpZ2h0JTIwdG8lMjBzZWUlMjBDZWxsZWN0YXIlMjBCaW9zY2llbmNlcyclMjBTRUMlMjBmaWxpbmdzLg==” button_text=”View Filings” button_url=”https://investor.cellectar.com/sec-filings” button_tdicon=”tdc-font-fa tdc-font-fa-chevron-right” button_size=”tdm-btn-md” content_align_vertical=”content-vert-center” tds_title1-title_color=”#2eb22c” tds_button1-background_color=”#2eb22c” content_align_horizontal=”content-horiz-left” tds_call_to_action=”tds_call_to_action2″][/vc_column][/vc_row][vc_row][vc_column][vc_separator][/vc_column][/vc_row][vc_row full_width=”stretch_row_content td-stretch-content”][vc_column][tdm_block_hero title_text=”R2V0JTIwRlJFRSUyMFN0b2NrJTIwQWxlcnRz” title_size=”tdm-title-bg” description=”U2lnbiUyMHVwJTIwZm9yJTIwb3VyJTIwRlJFRSUyMG1haWxpbmclMjBsaXN0JTIwYmVsb3clMjB0byUyMHJlY2VpdmUlMjByZWFsLXRpbWUlMjBhbGVydHMlMjBzZW50JTIwZGlyZWN0bHklMjB0byUyMHlvdXIlMjBpbmJveCE=” button_text=”Get Free Alerts” button_tdicon=”tdc-font-fa tdc-font-fa-chevron-right” button_url=”http://eepurl.com/gDrCzD” tds_button=”tds_button3″ button_size=”tdm-btn-lg” button_url-1=”#” tds_button-1=”tds_button3″ button_size-1=”tdm-btn-lg” block_width=”1200″ content_align_horizontal=”content-horiz-center” content_align_vertical=”content-vert-center” background=”eyJ0eXBlIjoiZ3JhZGllbnQiLCJjb2xvcjEiOiJyZ2JhKDIyLDExMiwxOTEsMC44NSkiLCJjb2xvcjIiOiJyZ2JhKDAsMCwwLDAuODUpIiwibWl4ZWRDb2xvcnMiOltdLCJjc3MiOiJiYWNrZ3JvdW5kOiAtd2Via2l0LWxpbmVhci1ncmFkaWVudCgwZGVnLHJnYmEoMCwwLDAsMC44NSkscmdiYSgyMiwxMTIsMTkxLDAuODUpKTtiYWNrZ3JvdW5kOiBsaW5lYXItZ3JhZGllbnQoMGRlZyxyZ2JhKDAsMCwwLDAuODUpLHJnYmEoMjIsMTEyLDE5MSwwLjg1KSk7IiwiY3NzUGFyYW1zIjoiMGRlZyxyZ2JhKDAsMCwwLDAuODUpLHJnYmEoMjIsMTEyLDE5MSwwLjg1KSJ9″ button_tdicon-1=”tdc-font-fa tdc-font-fa-chevron-right” media_size_image_height=”200″ media_size_image_width=”300″ image=”1397″][td_block_text_with_title]

[/td_block_text_with_title][td_block_text_with_title custom_title=”Income Statement” f_post_font_size=”12″ header_color=”#2eb22c”]

This website/newsletter is owned, operated and edited by CNA Finance, LLC. Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “CNA Finance” refers to CNA Finance, LLC. This webpage/newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to publish information and promote small public companies. By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website. We do not advise any reader to take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners do not own any shares in stocks mentioned unless stated in page disclosures. If we own any shares we will list the information relevant to the stock and number of shares here. CNA Finance, parent company to Alpha Stock News, receives payment to publish content and promote publicly traded companies. Pursuant to an agreement between CNA Finance and Cellectar Biosciences, CNA Finance has been hired for a period beginning on 12/1/19 and ending on 12/31/19 to conduct digital advertising and marketing and publicly disseminate information about CLRB via Websites and Email. We have been paid an upfront payment of fifteen thousand dollars via bank wire transfer. We own zero shares of Cellectar Biosciences. This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated digital outreach efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of digital outreach marketing, which may end as soon as the marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct and Cellectar Biosciences has not approved the content of this site. Furthermore, CNA Finance often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice.

[/td_block_text_with_title][/tdc_zone]